Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution

Blood (2024) 144 (Supplement 1): 1293.

https://doi.org/10.1182/blood-2024-205098

Published: 2024

Journal Articles

Preclinical Characterization of the Anti-Leukemia Activity of the CD123 Antibody-Drug Conjugate, Pivekimab Sunirine (IMGN632)

Frances M. Cole, George S. Laszlo, Margaret C. Lunn-Halbert, Allie R. Kehret, Patrick A. Zweidler-McKay, Eduardo Rodríguez-Arbolí, David Wu, Kyle E. Nyberg, Junyang Li, Sheryl Y. T. Lim, Sribalaji Lakshmikanthan, Roland B. Walter

Blood (2024) 144 (Supplement 1): 2750.

https://doi.org/10.1182/blood-2024-200907

Published: 2024

Journal Articles

Heterogeneity of TP53 Mutations in Mantle Cell Lymphoma- Challenges in Risk Stratification and Subclassification

Carrie I Ho, David Wu, Qian Wu, Kevin Ng, Jenna M Voutsinas, Ryan C Lynch, Manoj P Menon, Christina Poh, Mazyar Shadman, Brian G Till, Chaitra S Ujjani, Ajay K Gopal, Stephen D Smith

Blood (2023) 142 (Supplement 1): 3047.

https://doi.org/10.1182/blood-2023-181440

Published: 2023

Journal Articles

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

Blood (2022) 140 (21): 2228–2247.

https://doi.org/10.1182/blood.2022015853

Published: 2022

Includes: Supplemental data

Journal Articles

Expert Curation of Somatic FLT3 Variants By the Clingen Somatic Hematologic Cancer Taskforce (ClinGen HCT)

Blood (2021) 138 (Supplement 1): 4387.

https://doi.org/10.1182/blood-2021-153546

Published: 2021

Journal Articles

Expert Curation of Somatic Variants in Hematological Malignancies By the Clingen Somatic Hematological Cancer Taskforce (ClinGen HCT)

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-143028

Published: 2020

Journal Articles

Machine Learning Based Predictive Model of 5-Year Survival in Multiple Myeloma Autologous Transplant Patients

Robert Chen, PhD, Sankeerth Garapati, David Wu, Sean Ko, Sam Falk, Djamilia Dierov, Adam Stasiw, Adomah S. Opong, ANP, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 2156.

https://doi.org/10.1182/blood-2019-129432

Published: 2019

Journal Articles

Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade

Blood (2019) 134 (Supplement_1): 1493.

https://doi.org/10.1182/blood-2019-131904

Published: 2019

Journal Articles

Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma

Chang Xu, Ally Studer, Xueyan Chen, MD, Eric Hoyle, David Wu, MD PhD, Zhengwei Mao, Brent L Wood, MD PhD

Blood (2019) 134 (Supplement_1): 1475.

https://doi.org/10.1182/blood-2019-131360

Published: 2019

Journal Articles

New approaches to molecular monitoring in CML (and other diseases)

Jerald Radich, Cecilia Yeung, David Wu

Blood (2019) 134 (19): 1578–1584.

https://doi.org/10.1182/blood.2019000838

Published: 2019

Journal Articles

Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes

Jasper Hsu, Andreea Reilly, Brian J. Hayes, Courtnee A. Clough, Eric Q. Konnick, Beverly Torok-Storb, Suleyman Gulsuner, David Wu, Pamela S. Becker, Siobán B. Keel, Janis L. Abkowitz, Sergei Doulatov

Blood (2019) 134 (2): 186–198.

https://doi.org/10.1182/blood.2018884338

Published: 2019

Includes: Supplemental data

Journal Articles

Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

Blood (2018) 132 (Supplement 1): 5849.

https://doi.org/10.1182/blood-2018-99-118979

Published: 2018

Journal Articles

Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion

Kirsty Wienand, PhD, Bjoern Chapuy, MDPhD, Chip Stewart, PhD, Andrew Dunford, MS, David Wu, MD PhD, Jaegil Kim, PhD, Atanas Kamburov, PhD, Fathima Zumla Cader, MD PhD MRCP, Matthew D. Ducar, MS, Aaron R. Thorner, PhD, Alexander T Heubeck, BS, Michael J Buonopane, BS, Philippe Armand, MD PhD, Scott J Rodig, MD, Jonathan R. Fromm, MD PhD, Gad Getz, PhD, Margaret A. Shipp, MD

Blood (2018) 132 (Supplement 1): 1559.

https://doi.org/10.1182/blood-2018-99-118453

Published: 2018

Journal Articles

A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing

Claudia Wehr, Katja Grotius, Silvia Casadei, Dorothee Bleckmann, Sebastian F. N. Bode, Björn C. Frye, Maximilian Seidl, Suleyman Gulsuner, Mary-Claire King, Mary-Beth Percival, Colin C. Pritchard, Tom Walsh, David Wu, Siobán Keel, Ulrich Salzer

Blood (2018) 132 (11): 1211–1215.

https://doi.org/10.1182/blood-2018-03-837336

Published: 2018

Includes: Supplemental data

Journal Articles

Mass cytometry of Hodgkin lymphoma reveals a CD4 + regulatory T-cell–rich and exhausted T-effector microenvironment

Fathima Zumla Cader, Ron C. J. Schackmann, Xihao Hu, Kirsty Wienand, Robert Redd, Bjoern Chapuy, Jing Ouyang, Nicole Paul, Evisa Gjini, Mikel Lipschitz, Philippe Armand, David Wu, Jonathan R. Fromm, Donna Neuberg, X. Shirley Liu, Scott J. Rodig, Margaret A. Shipp

Blood (2018) 132 (8): 825–836.

https://doi.org/10.1182/blood-2018-04-843714

Published: 2018

Includes: Multimedia, Supplemental data

Journal Articles

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Brent Wood, David Wu, Beryl Crossley, Yunfeng Dai, David Williamson, Charles Gawad, Michael J. Borowitz, Meenakshi Devidas, Kelly W. Maloney, Eric Larsen, Naomi Winick, Elizabeth Raetz, William L. Carroll, Stephen P. Hunger, Mignon L. Loh, Harlan Robins, Ilan Kirsch

Blood (2018) 131 (12): 1350–1359.

https://doi.org/10.1182/blood-2017-09-806521

Published: 2018

Includes: Supplemental data

Journal Articles

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Yi Zhou, MD, Megan Othus, PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD, David Wu, MD PhD, Brent Wood, MDPhD

Blood (2017) 130 (Supplement 1): 2701.

https://doi.org/10.1182/blood.V130.Suppl_1.2701.2701

Published: 2017

Journal Articles

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Blood (2017) 129 (12): 1646–1657.

https://doi.org/10.1182/blood-2016-10-746933

Published: 2017

Journal Articles

Detection of Mutations in Inherited Bone Marrow Failure and Myelodysplastic Syndrome Genes Using Genomic Capture and Massively Parallel Sequencing in Clinical Diagnostics

Siobán B. Keel, MD, Tom Walsh, PhD, Colin Pritchard, MD, Akiko Shimamura, MD PhD, Mary-Claire King, PhD, David Wu, MD PhD

Blood (2016) 128 (22): 1507.

https://doi.org/10.1182/blood.V128.22.1507.1507

Published: 2016

Journal Articles

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Brent L. Wood, MD PhD, David Wu, MD PhD, Ilan M. Kirsch, MD, Beryl Crossley, BS, David Williamson, Charles Gawad, MD, Michael J. Borowitz, MD PhD, Meenakshi Devidas, PhD, Kelly W. Maloney, MD, Eric Larsen, MD, Naomi Winick, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Harlan Robins, PhD

Blood (2016) 128 (22): 1086.

https://doi.org/10.1182/blood.V128.22.1086.1086

Published: 2016

NARROW

iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution

Preclinical Characterization of the Anti-Leukemia Activity of the CD123 Antibody-Drug Conjugate, Pivekimab Sunirine (IMGN632)

Heterogeneity of TP53 Mutations in Mantle Cell Lymphoma- Challenges in Risk Stratification and Subclassification

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

Expert Curation of Somatic FLT3 Variants By the Clingen Somatic Hematologic Cancer Taskforce (ClinGen HCT)

Expert Curation of Somatic Variants in Hematological Malignancies By the Clingen Somatic Hematological Cancer Taskforce (ClinGen HCT)

Machine Learning Based Predictive Model of 5-Year Survival in Multiple Myeloma Autologous Transplant Patients

Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade

Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma

New approaches to molecular monitoring in CML (and other diseases)

Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes

Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion

A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing

Mass cytometry of Hodgkin lymphoma reveals a CD4 + regulatory T-cell–rich and exhausted T-effector microenvironment

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Detection of Mutations in Inherited Bone Marrow Failure and Myelodysplastic Syndrome Genes Using Genomic Capture and Massively Parallel Sequencing in Clinical Diagnostics

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only